Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin

BACKGROUND: Myxoid liposarcoma is a histological subtype of liposarcoma particularly sensitive to trabectedin. In clinical use this drug does not cause cumulative toxicity, allowing prolonged treatment, generally until disease progression. No other effective therapies are available for trabectedin-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bello, Ezia, Brich, Silvia, Craparotta, Ilaria, Mannarino, Laura, Ballabio, Sara, Gatta, Raffaella, Marchini, Sergio, Carrassa, Laura, Matteo, Cristina, Sanfilippo, Roberta, Gronchi, Alessandro, Casali, Paolo Giovanni, Pilotti, Silvana, D’Incalci, Maurizio, Frapolli, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738121/
https://www.ncbi.nlm.nih.gov/pubmed/31409911
http://dx.doi.org/10.1038/s41416-019-0550-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738121/
https://www.ncbi.nlm.nih.gov/pubmed/31409911
http://dx.doi.org/10.1038/s41416-019-0550-2

Ejemplares similares